Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MDNA - Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q3 2022 Results - Earnings Call Transcript

MDNA - Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q3 2022 Results - Earnings Call Transcript

Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. (MDNA) Q3 2022 Earnings Conference Call February 9, 2022 8:30 a.m. ET Company Participants Fahar Merchant - President & CEO Liz Williams - CFO Martin Bexon - CMO Rosemina Merchant - CDO Dan Ferry - LifeSci Advisors, IR Conference Call Participants Matt Biegler - Oppenheimer & Co. Inc. David Martin - Bloom Burton Swayampakula Ramakanth - H.C. Wainwright & Co. Shubhendu Roy - Brookline Capital Markets David Bautz - Zacks Small-Cap Research. Presentation Operator Greetings, and welcome to Medicenna Therapeutics Third Quarter Fiscal 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator instructions]. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Dan Ferry of LifeSci Advisors. Please go ahead. Dan Ferry Thank you, operator, and thank you all for participating in

For further details see:

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q3 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Medicenna Therapeutics Corp.
Stock Symbol: MDNA
Market: NASDAQ
Menu
MDNA MDNA Quote MDNA Short MDNA News MDNA Articles MDNA Message Board
Get MDNA Alerts

News, Short Squeeze, Breakout and More Instantly...